NYSE: HNGE
Hinge Health Inc Stock Forecast, Predictions & Price Target

Analyst price target for HNGE

Based on 13 analysts offering 12 month price targets for Hinge Health Inc

Min Forecast
$41.00-26.89%
Avg Forecast
$55.54-0.97%
Max Forecast
$65.00+15.91%

Should I buy or sell HNGE stock?

Based on 13 analysts offering ratings for Hinge Health Inc.

Strong Buy
Strong Buy
8 analysts 61.54%
Buy
5 analysts 38.46%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HNGE's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates HNGE as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their HNGE stock forecasts and price targets.

HNGE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-06
lockedlocked$00.00+00.00%2025-08-06
lockedlocked$00.00+00.00%2025-08-06
lockedlocked$00.00+00.00%2025-08-06
lockedlocked$00.00+00.00%2025-08-06
Bank of America
Top 5%
96
Strong BuyMaintains$64.00+14.12%2025-08-06Find out why
Morgan Stanley
Top 24%
77
Strong BuyMaintains$57.00+1.64%2025-08-06Find out why
Stifel Nicolaus
Top 13%
88
Strong BuyMaintains$55.00-1.93%2025-08-01
KeyBanc
Bottom 4%
4
Strong BuyMaintains$60.00+6.99%2025-07-14
Truist Securities
Bottom 1%
1
Strong BuyInitiates Coverage On$48.00-14.41%2025-06-16

1 of 2

Forecast return on equity

Is HNGE forecast to generate an efficient return?

Company
N/A
Industry
17.36%
Market
-51.7%

Forecast return on assets

Is HNGE forecast to generate an efficient return on assets?

Company
N/A
Industry
13.67%

HNGE earnings per share forecast

What is HNGE's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$6.04
Avg 2 year Forecast
$0.24
Avg 3 year Forecast
$0.26

HNGE revenue forecast

What is HNGE's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$551.1M
Avg 2 year Forecast
$650.5M
Avg 3 year Forecast
$754.8M

HNGE vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
HNGE$56.08$55.54-0.97%Strong Buy
BTSG$23.69$26.00+9.75%Strong Buy
WGS$129.49$104.00-19.68%Strong Buy
PRVA$23.04$28.63+24.24%Buy
WAY$37.88$47.20+24.60%Strong Buy

Hinge Health Stock Forecast FAQ

Is Hinge Health Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NYSE: HNGE) stock is to Strong Buy HNGE stock.

Out of 13 analysts, 8 (61.54%) are recommending HNGE as a Strong Buy, 5 (38.46%) are recommending HNGE as a Buy, 0 (0%) are recommending HNGE as a Hold, 0 (0%) are recommending HNGE as a Sell, and 0 (0%) are recommending HNGE as a Strong Sell.

If you're new to stock investing, here's how to buy Hinge Health stock.

What is HNGE's earnings growth forecast for 2025-2027?

(NYSE: HNGE) Hinge Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 19.68%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.89%.

Hinge Health's earnings in 2025 is N/A.On average, 2 Wall Street analysts forecast HNGE's earnings for 2025 to be -$473,356,716, with the lowest HNGE earnings forecast at -$489,435,941, and the highest HNGE earnings forecast at -$457,277,490. On average, 2 Wall Street analysts forecast HNGE's earnings for 2026 to be $18,432,283, with the lowest HNGE earnings forecast at $3,921,762, and the highest HNGE earnings forecast at $32,942,804.

In 2027, HNGE is forecast to generate $20,000,988 in earnings, with the lowest earnings forecast at $3,137,410 and the highest earnings forecast at $36,864,566.

What is HNGE's revenue growth forecast for 2025-2027?

(NYSE: HNGE) Hinge Health's forecast annual revenue growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.

Hinge Health's revenue in 2025 is N/A.On average, 6 Wall Street analysts forecast HNGE's revenue for 2025 to be $43,228,802,032, with the lowest HNGE revenue forecast at $43,060,950,603, and the highest HNGE revenue forecast at $43,539,405,610. On average, 7 Wall Street analysts forecast HNGE's revenue for 2026 to be $51,023,069,396, with the lowest HNGE revenue forecast at $48,041,588,788, and the highest HNGE revenue forecast at $52,661,424,836.

In 2027, HNGE is forecast to generate $59,205,120,623 in revenue, with the lowest revenue forecast at $55,547,841,925 and the highest revenue forecast at $63,203,122,033.

What is HNGE's forecast return on assets (ROA) for 2025-2028?

(NYSE: HNGE) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 13.67%.

What is HNGE's Price Target?

According to 13 Wall Street analysts that have issued a 1 year HNGE price target, the average HNGE price target is $55.54, with the highest HNGE stock price forecast at $65.00 and the lowest HNGE stock price forecast at $41.00.

On average, Wall Street analysts predict that Hinge Health's share price could fall to $55.54 by Aug 6, 2026. The average Hinge Health stock price prediction forecasts a potential downside of 0.97% from the current HNGE share price of $56.08.

What is HNGE's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: HNGE) Hinge Health's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that HNGE's EPS will be -$6.04 for 2025, with the lowest EPS forecast at -$6.24, and the highest EPS forecast at -$5.83. On average, analysts forecast that HNGE's EPS will be $0.24 for 2026, with the lowest EPS forecast at $0.05, and the highest EPS forecast at $0.42. In 2027, HNGE's EPS is forecast to hit $0.26 (min: $0.04, max: $0.47).

What is HNGE's forecast return on equity (ROE) for 2025-2028?

(NYSE: HNGE) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.